Genomic Analysis of Cutaneous CD30-Positive Lymphoproliferative Disorders
Primary cutaneous CD30+ T-cell lymphoproliferative disorders are the second most common cutaneous lymphomas. According to the World Health Organization, CD30+ T-cell lymphoproliferative disorders include primary cutaneous anaplastic large cell lymphoma (C-ALCL) and lymphomatoid papulosis (LyP) as we...
Saved in:
Main Authors: | Farah R. Abdulla (Author), Weiwei Zhang (Author), Xiwei Wu (Author), Kord Honda (Author), Hanjun Qin (Author), Hyejin Cho (Author), Christiane Querfeld (Author), Jasmine Zain (Author), Steven Terry Rosen (Author), Wing C. Chan (Author), Vishwas Parekh (Author), Joo Y. Song (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Remittance of primary cutaneous CD30+ lymphoproliferative disorder in a patient on adalimumab
by: Rosanne Ottevanger, MD, et al.
Published: (2022) -
CD30-Positive T-Cell Lymphoproliferative Disease of the Oral Mucosa in Children: A Manifestation of Epstein-Barr Virus-Associated T-Lymphoproliferative Disorder
by: Mineui Hong, et al.
Published: (2015) -
Addendum to "Remittance of primary cutaneous CD30+ lymphoproliferative disorder in a patient on adalimumab"
by: Rosanne Ottevanger, MD, et al.
Published: (2024) -
Primary Cutaneous CD30+ Lymphoproliferative Disorders in a Patient with Severe Atopic Dermatitis: Is There a Causative Link?
by: Magdalena Zychowska, et al.
Published: (2017) -
Efficacy of brentuximab vedotin in patients with CD30-positive lymphoproliferative skin diseases: results of the first prospective study in the Russian Federation
by: Irena E. Belousova, et al.
Published: (2022)